Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.48 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.48 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.48 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.48 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | EP300 | Q09472 | 1/20 | 0.48 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.48 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.48 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.48 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL11316461 | 1.00 | BID (0.48) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL11602995 | 1.00 | BID (0.48) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL6855037 | 1.00 | BID (0.48) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL6254721 | 1.00 | BID (0.48) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL1671202 | 0.97 | BID (0.50) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL6198089 | 0.97 | BID (0.50) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL5472319 | 0.95 | BID (0.49) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL3672989 | 0.95 | LIPG (0.51) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ether SCHEMBL8933110 | 0.95 | LIPG (0.51) | BIDMCL1BCL2L1BAK1KAT8 | |
| Cyclopentane SCHEMBL8723159 | 0.93 | BID (0.47) | BIDMCL1BCL2L1BAK1KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6921537-B2 | Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci | WYETH (US) | 2005-07-26 | — | — | US | claimed |
| EP-1206189-B1 | ROTAVIRUS VACCINE FORMULATIONS | MERCK & CO INC (US) | 2005-06-01 | — | — | EP | claimed |
| US-6616931-B1 | Containing sugar; phosphate; carboxylate; recombinant human serum albumin or a nonionic surfactant | MERCK & CO., INC. | 2003-09-09 | — | — | US | claimed |
| EP-1206189-A4 | ROTAVIRUS VACCINE FORMULATIONS | MERCK & CO INC (US) | 2003-03-12 | — | — | EP | claimed |
| US-20020136741-A1 | Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci | AMERICAN CYANAMID COMPANY (US) | 2002-09-26 | — | — | US | claimed |
| EP-1206189-A1 | ROTAVIRUS VACCINE FORMULATIONS | Merck & Co., Inc. (US) | 2002-05-22 | — | — | EP | claimed |
| US-6355253-B1 | BACTERICIDAL ANTIBODIES | AMERICAN CYANAMID COMPANY | 2002-03-12 | — | — | US | claimed |
| WO-2002011540-A1 | ROTAVIRUS VACCINE FORMULATIONS | MERCK & CO., INC. (US) | 2002-02-14 | — | — | WO | claimed |
| WO-2001008495-A1 | ROTAVIRUS VACCINE FORMULATIONS | MERCK & CO., INC. (US) | 2001-02-08 | — | — | WO | claimed |
| US-5521067-A | Bone marrow cell adhesion molecules and process for detecting adherence between cell adhesion molecules and cells generally | UNIVERSITY OF ROCHESTER (US) | 1996-05-28 | — | — | US | claimed |
| WO-1995014711-A1 | CELL ADHESION MOLECULES AND DETECTING ADHERENCE | UNIVERSITY OF ROCHESTER (US) | 1995-06-01 | — | — | WO | claimed |
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | claimed |
| US-5335373-A | Protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-08-09 | — | — | US | claimed |
| US-20240192707-A1 | MICROFLUIDIC SYSTEM | THE UNIVERSITY OF CHICAGO | 2024-06-13 | — | — | US | disclosed |
| US-20240160231-A1 | MICROFLUIDIC SYSTEM | THE UNIVERSITY OF CHICAGO | 2024-05-16 | — | — | US | disclosed |
| US-11853087-B2 | Microfluidic system | THE UNIVERSITY OF CHICAGO (US) | 2023-12-26 | — | — | US | disclosed |
| WO-1995014711-A1 | CELL ADHESION MOLECULES AND DETECTING ADHERENCE | UNIVERSITY OF ROCHESTER (US) | 1995-06-01 | — | — | WO | disclosed |
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | disclosed |
| US-5335373-A | Protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-08-09 | — | — | US | disclosed |
| EP-0477972-A2 | Nucleotide sequences useful as type-specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods | ABBOTT LABORATORIES (US) | 1992-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020136741-A1 | Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci | DDOST, STT3B, STT3A | BID 3129/4885MCL1 895/4885BCL2L1 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.